Lucid Diagnostics Inc.

NASDAQ: LUCD · Real-Time Price · USD
1.01
0.03 (2.95%)
At close: Aug 15, 2025, 3:59 PM
1.00
-0.99%
After-hours: Aug 15, 2025, 05:57 PM EDT

Lucid Diagnostics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.16M 828K 1.2M 1.17M 976K 1M 1.04M 783K 159K 446K 112K 76K n/a 189K 300K 200K n/a n/a
Cost of Revenue
1.78M 1.55M 2.15M 1.68M 1.61M 1.66M 1.46M 1.63M 1.55M 1.34M 1.62M 1.63M 704K 369K 440.73K 144.27K n/a 2.79K
Gross Profit
-622K -723K -948K -512K -638K -655K -417K -851K -1.39M -892K -1.51M -1.55M -704K -180K -141K 55.73K -219 -2.79K
Operating Income
-11.38M -12.49M -12.38M -11.69M -11.19M -10.79M -11.45M -11.13M -11.58M -14.32M -14.93M -14.38M -14.63M -12.27M -11.24M -6.51M -6.02M -3.65M
Interest Income
110K 66K 66K 81K 107K 68K 94K 116K 136K 78K n/a 28K 4K 1K n/a n/a n/a n/a
Pretax Income
-4.44M -26.91M -11.54M -12.37M -11.01M -10.61M -10.83M -14.21M -11.38M -16.25M -14.93M -14.35M -14.62M -12.27M -11.31M -6.96M -6.16M -3.65M
Net Income
-4.44M -26.91M -11.54M -12.37M -11.01M -10.61M -10.83M -14.21M -11.38M -1.98B -14.76M -14.35M -14.62M -12.27M -11.31M -6.96M -6.16M -3.65M
Selling & General & Admin
9.51M 10.23M 9.87M 9.41M 9.08M 8.26M 8.61M 8.16M 7.86M 11.03M 10.47M 9.59M 10.55M 9.21M 7.62M 4.38M 4.14M 1.9M
Research & Development
1.25M 1.43M 1.45M 1.67M 1.37M 1.5M 1.92M 1.61M 1.83M 1.89M 2.44M 2.7M 3.44M 2.88M 3.48M 2.19M 1.87M 1.75M
Other Expenses
n/a 105K 106K 105K 105K 372K 505K 505K 505K 505K 505K 505K n/a n/a n/a n/a n/a n/a
Operating Expenses
10.76M 11.76M 11.43M 11.18M 10.55M 10.14M 11.04M 10.28M 10.19M 13.43M 13.42M 12.8M 13.92M 12.09M 11.1M 6.57M 6.02M 3.65M
Interest Expense
6K 9K 7K 1K 6K 12K 11K 149K 223K 33K n/a n/a n/a n/a 65.19K 446.81K 147K n/a
Selling & Marketing Expenses
4.01B 4.07M 4M 4.06M 4.21M 4.19M 4.41M 3.84M 4.03M 4.13M 5.01M 3.93M 3.87M 3.32M 5.26M 918K 1.02M 689K
Cost & Expenses
12.55M 13.31M 13.57M -12.87M 12.17M 11.79M 12.49M 11.91M 11.74M 14.76M 15.04M 14.43M 14.62M 12.46M 11.54M 6.71M 6.02M 3.65M
Income Tax Expense
3.45B n/a n/a n/a n/a n/a n/a n/a n/a 1.96B -173K n/a 4K n/a 65.19K n/a n/a 219.00
Shares Outstanding (Basic)
98.99M 68.8M 57.7M 50.37M 48.21M 45.01M 41.76M 41.86M 41.83M 40.97M 37.34M 36.41M 35.76M 35.12M 36.99M 36.81M 36.99M 36.99M
Shares Outstanding (Diluted)
98.99M 68.8M 57.7M 50.37M 48.21M 45.01M 41.76M 41.86M 41.83M 40.97M 37.34M 36.41M 35.76M 35.12M 36.99M 36.99M 36.99M 36.99M
EPS (Basic)
-0.08 -0.52 -0.2 -0.25 -0.23 -0.4 -0.26 -0.34 -0.27 -48.31 -0.4 -0.39 -0.41 -0.35 -0.31 -0.19 -0.17 -0.1
EPS (Diluted)
-0.08 -0.52 -0.2 -0.25 -0.23 -0.4 -0.26 -0.34 -0.27 -48.31 -0.4 -0.39 -0.41 -0.35 -0.31 -0.19 -0.17 -0.1
EBITDA
-4.21M -26.68M -11.31M -12.15M -10.77M -10.1M -10.19M -13.43M -10.53M -15.6M -14.31M -13.76M -13.92M -12.25M -11.24M -6.51M -6.02M -3.65M
EBIT
-4.43M -26.9M -11.53M -12.37M -11M -10.6M -10.82M -14.06M -11.16M -16.21M -14.93M -14.35M -14.62M -12.27M -11.24M -6.51M -6.02M -3.65M
Depreciation & Amortization
222K 221K 222K 215K 229K 501K 629K 625K 633K 612K 615K 593K 704K 24K 556.00 440.00 219.00 2.79K